ChemPartner: ImmunoPrecise Antibodies and ChemPartner Biologics Announce PolyTope TATX-03 Antibody Cocktail Manufacturing Collaboration

"In light of the recent events as it pertains to concerns about vaccines and therapeutic antibodies losing efficacy against novel variants of concern, we believe that, if the preclinical data that we have to date is confirmed through human clinical studies, IPA is in a strong position to potentially address a worldwide need for alternative SARS-CoV-2 therapies using our Polytope cocktail.